NewslettersUmbilical & Placental Cell NewsManagement of Retinitis Pigmentosa Via Wharton’s Jelly-Derived Mesenchymal Stem Cells or Combination with Magnovision: Three-Year Prospective ResultsBy Laurisa Dohm - September 21, 20230168Researchers investigated whether the natural progression rate of retinitis pigmentosa could be decreased with subtenon Wharton’s jelly-derived MSC application alone, or combination with Magnovision.[Stem Cells Translational Medicine]Full ArticleGraphical Abstract